JP2020518644A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518644A5
JP2020518644A5 JP2019560725A JP2019560725A JP2020518644A5 JP 2020518644 A5 JP2020518644 A5 JP 2020518644A5 JP 2019560725 A JP2019560725 A JP 2019560725A JP 2019560725 A JP2019560725 A JP 2019560725A JP 2020518644 A5 JP2020518644 A5 JP 2020518644A5
Authority
JP
Japan
Prior art keywords
aav
agent
aav2
subject
serotype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560725A
Other languages
English (en)
Japanese (ja)
Other versions
JP7450244B2 (ja
JP2020518644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030615 external-priority patent/WO2018204475A1/en
Publication of JP2020518644A publication Critical patent/JP2020518644A/ja
Publication of JP2020518644A5 publication Critical patent/JP2020518644A5/ja
Application granted granted Critical
Publication of JP7450244B2 publication Critical patent/JP7450244B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560725A 2017-05-02 2018-05-02 虚血組織を治療するための方法 Active JP7450244B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762500470P 2017-05-02 2017-05-02
US62/500,470 2017-05-02
PCT/US2018/030615 WO2018204475A1 (en) 2017-05-02 2018-05-02 Method for treating ischemic tissue

Publications (3)

Publication Number Publication Date
JP2020518644A JP2020518644A (ja) 2020-06-25
JP2020518644A5 true JP2020518644A5 (cg-RX-API-DMAC7.html) 2021-07-26
JP7450244B2 JP7450244B2 (ja) 2024-03-15

Family

ID=64016314

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019560725A Active JP7450244B2 (ja) 2017-05-02 2018-05-02 虚血組織を治療するための方法

Country Status (9)

Country Link
US (1) US20200062820A1 (cg-RX-API-DMAC7.html)
EP (1) EP3618852A4 (cg-RX-API-DMAC7.html)
JP (1) JP7450244B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200013674A (cg-RX-API-DMAC7.html)
CN (1) CN110769861A (cg-RX-API-DMAC7.html)
AU (1) AU2018261420A1 (cg-RX-API-DMAC7.html)
CA (1) CA3097135A1 (cg-RX-API-DMAC7.html)
IL (1) IL270388B2 (cg-RX-API-DMAC7.html)
WO (1) WO2018204475A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102545491B1 (ko) * 2020-08-13 2023-06-21 동국대학교 산학협력단 신규한 뇌혈관질환 동물모델 제조방법 및 이에 의해 제조된 뇌혈관질환 동물모델을 이용하여 뇌혈관질환 발병 감수성 개체 차이가 작은 동물을 생산하기 위한 방법
US20240237960A1 (en) * 2021-06-11 2024-07-18 Jubilant Draximage Inc. Expert scoring system for measurement of severity, treatment response and prognosis of peripheral arterial disease
EP4694905A1 (en) * 2023-04-13 2026-02-18 University of Miami Method for promoting myogenesis and skeletal muscle recovery
CN121570599B (zh) * 2026-01-27 2026-05-15 中山大学中山眼科中心 Sele在湿性年龄相关性黄斑变性治疗中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016761A2 (en) * 2002-08-16 2004-02-26 Schering Aktiengesellschaft Gene therapy for critical limb ischemia with wild type or mutant enos
CN102421894A (zh) * 2009-04-21 2012-04-18 迈阿密大学 用于促进局部缺血性和糖尿病性创面愈合的组合物、试剂盒和方法
WO2011053896A2 (en) * 2009-10-30 2011-05-05 University Of Miami Hypoxia regulated conditionally silenced aav expressing angiogenic inducers

Similar Documents

Publication Publication Date Title
CL2020000728A1 (es) Variantes de cápsides de virus adenoasociados y métodos de uso de estas.
CL2020001360A1 (es) Cápsides variantes de virus adenoasociados y su uso para inhibir la angiogénesis.
JP2020514286A5 (cg-RX-API-DMAC7.html)
JP2019513794A5 (cg-RX-API-DMAC7.html)
JP2018537984A5 (cg-RX-API-DMAC7.html)
JP2009545310A5 (cg-RX-API-DMAC7.html)
JP2018148927A5 (cg-RX-API-DMAC7.html)
JP2004506658A5 (cg-RX-API-DMAC7.html)
AR124119A2 (es) Partículas virales modificadas y usos de estas
JP2018527365A5 (cg-RX-API-DMAC7.html)
US10525091B2 (en) Use of parvovirus for eliminating cancer stem cells (CSCs)
AU2018261420A1 (en) Method for treating ischemic tissue
MX2023002695A (es) Virus adeno-asociado para la administración de kh902 (conbercept) y usos del mismo.
JP2017522288A5 (cg-RX-API-DMAC7.html)
CL2023001876A1 (es) Proteínas de la cápside viral con especificidad para las células del tejido cardiaco
JP2020527167A5 (cg-RX-API-DMAC7.html)
JP2012524781A5 (cg-RX-API-DMAC7.html)
Wang MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
Dhal et al. Translational regenerative medicine—hepatic systems
JP5765790B2 (ja) ラットパルボウイルスh−1pvのそのカプシドの遺伝子操作による癌細胞への再標的化
JP2017502058A5 (cg-RX-API-DMAC7.html)
ES2436317T3 (es) Parvovirus de roedor modificado capaz de propagarse y difundirse en gliomas humanos
DK2720702T3 (en) Oncolytic virus therapy for the therapy of Ewing's sarcoma
JP2018502838A5 (cg-RX-API-DMAC7.html)
Bauer et al. The hazards of habituation in healthcare: are we too content at being complacent?